Rebus Holdings, Inc. (RBSH)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 11, 2025
Market Cap3.21K
Revenue (ttm)n/a
Net Income (ttm)570.00K
Shares Out32.13M
EPS (ttm)0.02
PE Ratio0.01
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,500
Average Volume4,949
Open0.0001
Previous Close0.0001
Day's Range0.0001 - 0.0001
52-Week Range0.0000 - 0.0002
Beta-27.57
RSI42.31
Earnings Daten/a

About Rebus Holdings

Rebus Holdings, Inc., together with its subsidiaries, focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. Rebus Holdings, Inc. was incorporated in 2003 and is based in Westlake Village, California. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol RBSH
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.